BOSTON--(BUSINESS WIRE)--TA Associates, a leading global growth private equity firm, today announced the sale of its portfolio company American Access Care (AAC) to Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME, New York Stock Exchange: FMS). AAC is a rapidly growing operator of outpatient vascular access centers serving individuals with end-stage renal disease (ESRD), commonly known as kidney failure. Fresenius Medical Care is the world’s leading company devoted to patient-oriented renal therapy. TA completed a $130 million minority leveraged recapitalization of AAC in October 2006. The company is based in Glen Rock, Pennsylvania.
"TA Associates is very pleased to have been associated with AAC during a remarkable growth period," said David S. B. Lang, an Advisor at TA Associates who was on the Board of American Access Care. "This is a very strategic combination of two of the most forward thinking companies in the healthcare delivery marketplace."
“In addition to a flexible financial structure, TA provided the strategic guidance and network of contacts to facilitate our growth,” said Raymond Figueroa, Chief Executive Officer of American Access Care. “It has been a pleasure working with such talented and experienced investors.”
TA Associates has more than four decades of investing experience, focusing on profitable growth companies. TA’s prior investments in the healthcare sector include Alere Medical, Amann Girrbach, AmeriChoice, CompBenefits, Dr Lal PathLabs, Invitrogen, MedSolutions, Millennium Laboratories, MQ Associates, National Imaging Associates, Triumph HealthCare and Twin Med.
“During five years as a TA portfolio company, AAC grew from 14 to 29 freestanding interventional centers and increased procedure volumes by over 4x,” said Todd R. Crockett, a Managing Director at TA Associates who was also on the Board of American Access Care. “It has been gratifying to play a part in such significant growth, and we wish Ray, the management team and the AAC Board much continued success.”
Goodwin Procter LLP provided legal counsel to TA Associates.
About American Access Care
American Access Care is a management company operating freestanding outpatient vascular access centers dedicated to patients suffering from end-stage renal disease (ESRD). The centers fulfill the unmet needs of dialysis patients for timely, reliable, safe, cost-efficient vascular access procedures. The company’s board-certified interventional radiologists, vascular surgeons and interventional nephrologists are subject matter experts and many were pioneers in their fields. Founded in 2001, the company operates 29 centers in 12 states, and is based in Glen Rock, PA. For more information, visit www.americanaccesscare.com.
About TA Associates
Founded in 1968, TA Associates is one of the largest and most experienced middle-market growth private equity firms. The firm has invested in over 400 companies globally and has raised more than $16 billion in capital. With offices in Boston, Menlo Park, London, Mumbai and Hong Kong, TA Associates leads buyouts and minority recapitalizations of profitable growth companies in the technology, financial services, business services, healthcare and consumer industries. More information about TA Associates can be found at www.ta.com.